YY2201 is a potent, selective inhibitor of ATR with an IC50 of 8 nM. It exhibits over 200 times greater selectivity for ATR compared to mTOR. Additionally, YY2201 is capable of inhibiting tumor progression across a wide range of cancer types.
Target:
ATM/ATR
* VAT and and shipping costs not included. Errors and price changes excepted
